KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jan 29, 2026 >>  ABB India 5475.9  [ 8.52% ]  ACC 1677.7  [ -0.46% ]  Ambuja Cements 536  [ 0.39% ]  Asian Paints 2416.7  [ -3.75% ]  Axis Bank 1364.35  [ 3.32% ]  Bajaj Auto 9507.75  [ 0.77% ]  Bank of Baroda 302.5  [ -1.19% ]  Bharti Airtel 1968.15  [ 0.57% ]  Bharat Heavy 260.4  [ 0.29% ]  Bharat Petroleum 366.9  [ 1.24% ]  Britannia Industries 5725.55  [ -0.34% ]  Cipla 1320.35  [ -0.59% ]  Coal India 455.9  [ 2.62% ]  Colgate Palm 2111.85  [ -1.94% ]  Dabur India 508.6  [ -1.37% ]  DLF 638.3  [ 2.06% ]  Dr. Reddy's Labs 1208.45  [ -1.29% ]  GAIL (India) 167.3  [ -0.48% ]  Grasim Industries 2832.95  [ -0.35% ]  HCL Technologies 1721.15  [ -0.53% ]  HDFC Bank 935.65  [ 0.32% ]  Hero MotoCorp 5576.9  [ 1.38% ]  Hindustan Unilever 2351.65  [ -1.21% ]  Hindalco Industries 1024.8  [ 2.61% ]  ICICI Bank 1384.1  [ 1.22% ]  Indian Hotels Co. 664.6  [ 1.26% ]  IndusInd Bank 898.1  [ -0.37% ]  Infosys 1657.7  [ -0.52% ]  ITC 318.65  [ -0.81% ]  Jindal Steel 1155.2  [ 3.23% ]  Kotak Mahindra Bank 412.35  [ -0.01% ]  L&T 3932.45  [ 3.66% ]  Lupin 2131.8  [ 0.48% ]  Mahi. & Mahi 3385.5  [ -1.83% ]  Maruti Suzuki India 14499.5  [ -2.54% ]  MTNL 30.81  [ -1.57% ]  Nestle India 1287.75  [ -0.38% ]  NIIT 75.9  [ 0.78% ]  NMDC 84.7  [ 3.91% ]  NTPC 358.1  [ 2.84% ]  ONGC 275.25  [ 2.46% ]  Punj. NationlBak 125.2  [ 0.56% ]  Power Grid Corpo 260.55  [ 0.31% ]  Reliance Industries 1391.9  [ -0.37% ]  SBI 1064.5  [ 0.16% ]  Vedanta 766.1  [ 3.93% ]  Shipping Corpn. 222.35  [ 0.82% ]  Sun Pharmaceutical 1589.3  [ -1.29% ]  Tata Chemicals 723.45  [ -0.52% ]  Tata Consumer Produc 1106.2  [ -2.29% ]  Tata Motors Passenge 351.85  [ 3.35% ]  Tata Steel 202.35  [ 4.41% ]  Tata Power Co. 366.4  [ 3.20% ]  Tata Consultancy 3146.1  [ -1.68% ]  Tech Mahindra 1767.8  [ 0.30% ]  UltraTech Cement 12719.5  [ -0.39% ]  United Spirits 1330.9  [ 0.27% ]  Wipro 239.85  [ 1.03% ]  Zee Entertainment En 82.98  [ -1.18% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

BROOKS LABORATORIES LTD.

29 January 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE650L01011 BSE Code / NSE Code 533543 / BROOKS Book Value (Rs.) 39.27 Face Value 10.00
Bookclosure 19/09/2024 52Week High 165 EPS 0.00 P/E 0.00
Market Cap. 182.34 Cr. 52Week Low 62 P/BV / Div Yield (%) 1.58 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Our Company was incorporated vide a Certificate of Incorporation dated January 23, 2002 bearing CIN No. U24232PB2002PLC24910 under the Companies Act 1956 with the name `Brooks Laboratories Limited' by our promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan. We received our certificate of commencement of business on February 19, 2002, from the Registrar of Companies, Punjab, Himachal Pradesh & Chandigarh at Jalandhar. Our Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. Our Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development ("R&D") centre at Baddi, Himachal Pradesh. Our Company started its commercial production in the month of June 2006. Our Company became profitable from the very first year of its production. This facility at Baddi is WHO-GMP and ISO 9001:2008 certified. The facility focuses on developing latest molecules in the niche segments and then selling it to various pharmaceutical marketing Companies.

Before staring our company, our promoters were engaged in manufacturing of Pharmaceutical Formulations in their partnership firm namely Brooks Pharmaceuticals. The firm had a manufacturing facility at F-94, Industrial Area, Phase 7, Mohali, Punjab. The factory at Mohali had annual installed capacity of 30 Lacs Injectables, 300 Lacs Tablets and 15 Lacs Dry Syrups. Our promoters had a successful track record of running the manufacturing of formulations in the aforesaid firm, profitably for over 6 years. In order to take an advantage of the growing market and avail the tax and other benefits that were made available by the Government to set up a manufacturing facility at Baddi, our promoters decided incorporate our company Brooks Laboratories Ltd and set up a bigger and more sophisticated unit at Baddi, in Himachal Pradesh. Subsequently, the firm was dissolved in the month of December 2008. Further in years 2007 and 2008 to have a smooth transition from Brook Pharmaceuticals to Brooks Laboratories Ltd., Our Company paid/settled some dues to Creditors and Lenders of Brooks Pharmaceuticals aggregating to Rs. 151.79 Lacs. Later on to settle the above our Company purchased on book value certain assets (Fixed assets & Stocks) aggregating to Rs. 113.27 Lacs and received an aggregate sum of Rs. 38.52 Lacs from M/s. Brooks Pharmaceuticals, a partnership firm promoted by our Promoters, Mr. Atul Ranchal and Mr. Rajesh Mahajan.

Key Events and Milestones

January 23, 2002 Incorporation of Brooks Laboratories Limited.

February 19,2002 Received certificate for commencement of business

May 5, 2005 Commenced setting up of manufacturing facility at Baddi, Himachal Pradesh.

April 10,2006 Manufacturing drugs license issued by the State Drugs Controlling and Licensing Authority, HP.

April 30, 2005 Commissioning of R&D centre at Baddi

May 20,2006 Completion of Commissioning of plant for manufacture of Tablets, capsules, Injections, Oral Liquids etc.

May 30, 2006 Start of commercial production

June 1, 2006 First PPI Formulation developed by the Company.

October 27,2006 Obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules.

August 02, 2007 Received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Limited, Australia.

April 30, 2008* Takeover of some of the Assets of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan by our Company.

December 30, 2008 Dissolution of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan.

January 06,2009 Micro Small Medium Enterprise (MSME) Registration Certificate issued by Directorate of Industries for Manufacturing/Assembling Injections, Capsules & Tabulates (Single Window Clearance Agency).

April 7,2010 The manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP. July 27,2010 Received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF.

2012

--Registered Office of the Company has been shifted to Village Kishanpura, Nalagarh Road, Baddi, Distt. Solan, H.P

2013

-Mr. Bhaskar Sharma has been appointed as Additional Independent Director of the company.

2014

- Ms.Sonia Gupta has been appointed as Independent Director of the Company.

2015

-Brooks Laboratories - Shifting of Corporate Office to 5th Floor, Next to Hotel Courtyard Marriott, Andheri Kurla Road, Mumbai - 400093.

2016

-Brooks Laboratories gets manufacturing licence for Gujarat facility.

2023

-The company issued rights shares of Rs. 10 in the ratio of 1:16 at a premium of Rs. 65 per share.